Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2023-09-06 00:00:00 ET · period of report 2023-09-01 · accession 0001209191-23-048414 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-09-06 | 2023-09-01 | GMED | Norwalk Leslie V | Dir | A - Grant | — | +28.0K | 2,321 | New | — |
| D | 2023-09-06 | 2023-09-01 | GMED | Norwalk Leslie V | Dir | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-09-01 | A | A | 25,688 | — | 28,009 | D | — | — | (F2) Pursuant to the Merger Agreement, at the Effective Time of the Merger, each NuVasive restricted stock unit award was accelerated, cancelled and converted automatically into the right to receive 0.75 shares of Class A Common Stock, and cash in lieu of fractional shares, in respect of each share of NuVasive common stock underlying such award. |
| 2 | Common | Class A Common Stock | 2023-09-01 | A | A | 2,321 | — | 2,321 | D | — | — | (F1) Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the "Merger Agreement"), by and among the Issuer, NuVasive, Inc. ("NuVasive") and Zebra Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into NuVasive (the "Merger"), with NuVasive continuing as a wholly owned subsidiary of the Issuer. At the effective time of the Merger (the "Effective Time"), each share of common stock of NuVasive owned by the Reporting Person was automatically converted into 0.75 shares of Class A common stock of Issuer, par value $0.001 per share ("Class A Common Stock"), and cash in lieu of fractional shares. |
| 3 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2023-09-01 | A | A | 15,000 | $0.00 | 15,000 | D | $54.23 · — to 2033-09-01 | 15,000 Class A Common Stock | (F3) These options were granted on September 1, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on September 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |